Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11760763 Heteroaryl compounds useful as MK2 inhibitors

Patent 11760763 was granted and assigned to Bristol-Myers Squibb on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11760763

Patent Inventor Names

Jian Guo

John Malona

Sekhar S. Surapaneni

Alexander L. Ruchelman

Date of Patent

September 19, 2023

Patent Application Number

17477649

Date Filed

September 17, 2021

Patent Citations

‌

US Patent 9790235 MK2 inhibitors and uses thereof

‌

US Patent 10138256 MK2 inhibitors and uses thereof

‌

US Patent 10253040 MK2 inhibitors and uses thereof

‌

US Patent 10577380 MK2 inhibitors and uses thereof

‌

US Patent 10894796 MK2 inhibitors, synthesis thereof, and intermediates thereto

‌

US Patent 10882867 Forms and compositions of a MK2 inhibitor

‌

US Patent 11230551 Deuterated analogs of MK2 inhibitors and uses thereof

‌

US Patent 7517990 Method for deuteration of a heterocyclic ring

...

Patent Primary Examiner

CPC Code

Patent abstract

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11760763 Heteroaryl compounds useful as MK2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API